Plasmalogen loss caused by remodeling deficiency in mitochondria. 2019

Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada kimurat@mcmaster.ca.

Lipid homeostasis is crucial in human health. Barth syndrome (BTHS), a life-threatening disease typically diagnosed with cardiomyopathy and neutropenia, is caused by mutations in the mitochondrial transacylase tafazzin. By high-resolution 31P nuclear magnetic resonance (NMR) with cryoprobe technology, recently we found a dramatic loss of choline plasmalogen in the tafazzin-knockdown (TAZ-KD) mouse heart, besides observing characteristic cardiolipin (CL) alterations in BTHS. In inner mitochondrial membrane where tafazzin locates, CL and diacyl phosphatidylethanolamine are known to be essential via lipid-protein interactions reflecting their cone shape for integrity of respiratory chain supercomplexes and cristae ultrastructure. Here, we investigate the TAZ-KD brain, liver, kidney, and lymphoblast from patients compared with controls. We identified common yet markedly cell type-dependent losses of ethanolamine plasmalogen as the dominant plasmalogen class therein. Tafazzin function thus critically relates to homeostasis of plasmalogen, which in the ethanolamine class has conceivably analogous and more potent molecular functions in mitochondria than diacyl phosphatidylethanolamine. The present discussion of a loss of plasmalogen-protein interaction applies to other diseases with mitochondrial plasmalogen loss and aberrant forms of this organelle, including Alzheimer's disease.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D010955 Plasmalogens GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids. Phosphatidal Compounds,Plasmalogen,Alkenyl Ether Phospholipids,Compounds, Phosphatidal,Ether Phospholipids, Alkenyl,Phospholipids, Alkenyl Ether
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000217 Acyltransferases Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3. Acyltransferase

Related Publications

Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
September 2019, Brain pathology (Zurich, Switzerland),
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
March 2024, Free radical biology & medicine,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
January 2019, Redox biology,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
August 2022, The international journal of biochemistry & cell biology,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
August 2008, Journal of neurochemistry,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
July 2023, BMC neurology,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
April 2022, American journal of respiratory and critical care medicine,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
August 2019, Journal of cellular biochemistry,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
January 2003, Journal of lipid research,
Tomohiro Kimura, and Atsuko K Kimura, and Mindong Ren, and Vernon Monteiro, and Yang Xu, and Bob Berno, and Michael Schlame, and Richard M Epand
October 1986, Experimental neurology,
Copied contents to your clipboard!